A focus on young people with ulcerative colitis – do they take their treatment and what can GPs do to help?

<p>In this episode, we talk to Dr Nish Jayasooriya, Research Fellow and specialist registrar in gastroenterology and hepatology. </p><p><em>Paper: Adherence to 5-aminosalicylic acid maintenance treatment in young people with ulcerative colitis: a retrospective cohort study in primary care</em></p><p><strong>Available at: </strong><a href="https://doi.org/10.3399/BJGP.2023.0006" rel="noopener noreferrer" target="_blank"><strong>https://doi.org/10.3399/BJGP.2023.0006</strong></a></p><p>Adolescents and young adults diagnosed with ulcerative colitis (UC) are recommended long- term maintenance treatment for disease control, but adherence rates in primary care are unknown. This observational cohort study using real-world data from primary care found one-quarter of newly diagnosed adolescents and young adults, aged 10–24 years, discontinued oral 5-aminosalicylic acid (5-ASA) maintenance treatment within 1 month of starting and two-thirds within 1year. Young adults aged 18–24years and those living in a deprived area were most likely to discontinue and have poor adherence to treatment. Having an acute flare-up of UC was linked to better adherence to oral 5-ASA maintenance treatment. The first year of starting lifelong therapies among individuals diagnosed with UC is a critical window to improve adherence for adolescents transitioning to young adulthood and those from deprived postcodes.</p>